title: EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
abstract: Osteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women.
authors.affiliation: Palacios Institute of Woman's Health Antonio Acuna, Madrid, Spain. ipalacios@institutopalacios.com
authors.forename: Santiago
authors.initials: S
authors.lastname: Palacios
authors.forename: Mark
authors.initials: M
authors.lastname: Brincat
authors.forename: C Tamer
authors.initials: CT
authors.lastname: Erel
authors.forename: Marco
authors.initials: M
authors.lastname: Gambacciani
authors.forename: Irene
authors.initials: I
authors.lastname: Lambrinoudaki
authors.forename: Mette H
authors.initials: MH
authors.lastname: Moen
authors.forename: Karin
authors.initials: K
authors.lastname: Schenck-Gustafsson
authors.forename: Florence
authors.initials: F
authors.lastname: Tremollieres
authors.forename: Svetlana
authors.initials: S
authors.lastname: Vujovic
authors.forename: Margaret
authors.initials: M
authors.lastname: Rees
authors.forename: Serge
authors.initials: S
authors.lastname: Rozenberg
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D000069448:Denosumab; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D009942:Organometallic Compounds / Q000627:therapeutic use; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D009942:Organometallic Compounds; D020845:Selective Estrogen Receptor Modulators; D013876:Thiophenes; C081587:strontium ranelate; D000069448:Denosumab